ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Birmingham, AL, USA:

A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors (Minnelide 101)

and Pharmacodynamic Study of Minnelide™Capsules given daily for 21 days followed by 7 days off schedule in patients with Advanced Solid Tumors...

Enrolling
Solid Tumor
Advanced Cancer
Drug: Minnelide™Capsules

Phase 1

Minneamrita Therapeutics

Birmingham, Alabama, United States and 6 other locations

* To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants w...

Active, not recruiting
Metastatic Colorectal Cancer
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Cetuximab
Drug: ERAS-007

Phase 1, Phase 2

Erasca

Birmingham, Alabama, United States and 13 other locations

and clinical activity of ProAgio combined with gemcitabine and nab paclitaxel (G-nP) in previously untreated subjects with metastatic pancreatic...

Enrolling
Pancreatic Ductal Carcinoma
Drug: ProAgio Dose Levels (DL) 1,2,3,4
Drug: Gemcitabine, nab paclitaxel

Phase 1

ProDa BioTech

Birmingham, Alabama, United States

This study is open to adults with advanced solid tumors whose previous cancer treatment was not successful. People can participate ...

Active, not recruiting
Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Carcinoma, Hepatocellular, Head and Neck Neoplasms, Gastrointestinal Neoplasms
Drug: BI 765049
Drug: ezabenlimab

Phase 1

Boehringer Ingelheim
Boehringer Ingelheim

Birmingham, Alabama, United States and 13 other locations

The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific gen...

Enrolling
Ovarian Neoplasms
Biliary Tract Neoplasms
Drug: Cetuximab
Drug: Cisplatin

Phase 1, Phase 2

Lilly
Lilly

Birmingham, Alabama, United States and 49 other locations

liposome injection in combination with other approved drugs used for cancer therapy, namely 5 fluorouracil/leucovorin (5FU/LV) plus oxalipla ...

Active, not recruiting
Metastatic Adenocarcinoma of the Pancreas
Drug: Leucovorin
Drug: Gemcitabine

Phase 3

Ipsen
Ipsen

Birmingham, Alabama, United States and 199 other locations

To evaluate the efficacy of naporafenib administered with trametinib in patients with rat sarcoma viral oncogene (RAS) Q61X solid tumors* To...

Enrolling
Advanced or Metastatic Solid Tumors
Drug: Trametinib
Drug: Naporafenib

Phase 1

Erasca

Birmingham, Alabama, United States and 30 other locations

This study is about TAK-500, given either alone or with pembrolizumab, in adults with select locally advanced or metastatic solid tumors.The...

Enrolling
Breast Cancer
Nasopharyngeal Cancer
Drug: Pembrolizumab
Drug: TAK-500

Phase 1, Phase 2

Takeda
Takeda

Birmingham, Alabama, United States and 11 other locations

and clinical antitumor activity of XB002 administered IV q3w alone and in combination with nivolumab to subjects with advanced solid tumors....

Active, not recruiting
Endometrial Cancer
Tissue Factor-Expressing Solid Tumors
Drug: XB002
Drug: Nivolumab

Phase 1

Exelixis
Exelixis

Birmingham, Alabama, United States and 94 other locations

evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with advanced solid tumors...

Enrolling
Metastatic Cancer
Advanced Cancer
Drug: Cetuximab
Drug: Afatinib

Phase 1, Phase 2

Mirati Therapeutics
Mirati Therapeutics

Birmingham, Alabama, United States and 219 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems